Article Details

While children can exhibit symptoms of autism spectrum disorders (ASDs) before 18 months, the current average age of diagnosis is 4.5 years – well past the age where behavioral therapies can begin.

SynapDx is developing a test to shorten the time from suspicion of autism to diagnosis. They chose Illumina next-generation sequencing technology as the platform for designing performance characteristics and be the basis for their roll out as a diagnostic test. Their clinical trial, a 600-patient study called STORY, is currently in progress.

See the video at: http://www.youtube.com/watch?feature=player_embedded&v=gtgQe4J4hv4

Back to all News